Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Innate immune reconstitution with suppression of HIV-1
Eileen P. Scully, … , Ronald J. Bosch, Marcus Altfeld
Eileen P. Scully, … , Ronald J. Bosch, Marcus Altfeld
Published March 17, 2016
Citation Information: JCI Insight. 2016;1(3):e85433. https://doi.org/10.1172/jci.insight.85433.
View: Text | PDF
Research Article AIDS/HIV Immunology

Innate immune reconstitution with suppression of HIV-1

  • Text
  • PDF
Abstract

Progressive HIV-1 infection leads to both profound immune suppression and pathologic inflammation in the majority of infected individuals. While adaptive immune dysfunction, as evidenced by CD4+ T cell depletion and exhaustion, has been extensively studied, less is known about the functional capacity of innate immune cell populations in the context of HIV-1 infection. Given the broad susceptibility to opportunistic infections and the dysregulated inflammation observed in progressive disease, we hypothesized that there would be significant changes in the innate cellular responses. Using a cohort of patients with multiple samplings before and after antiretroviral therapy (ART) initiation, we demonstrated increased responses to innate immune stimuli following viral suppression, as measured by the production of inflammatory cytokines. Plasma viral load itself had the strongest association with this change in innate functional capacity. We further identified epigenetic modifications in the TNFA promoter locus in monocytes that are associated with viremia, suggesting a molecular mechanism for the observed changes in innate immune function following initiation of ART. These data indicate that suppression of HIV-1 viremia is associated with changes in innate cellular function that may in part determine the restoration of protective immune responses.

Authors

Eileen P. Scully, Ainsley Lockhart, Wilfredo Garcia-Beltran, Christine D. Palmer, Chelsey Musante, Eric Rosenberg, Todd M. Allen, J. Judy Chang, Ronald J. Bosch, Marcus Altfeld

×

Figure 1

T cell activation correlates with declining viral load.

Options: View larger image (or click on image) Download as PowerPoint
T cell activation correlates with declining viral load.
CD8+ (A) and CD4...
CD8+ (A) and CD4+ (B) T cell activation as defined by CD38 and HLA-DR coexpression correlated with declining viral load after initiation of ART. (C) Representative flow cytometric results for T cell activation with corresponding plasma viral load measures. (D) Recovery of CD4+ T cell count as related to viral load. Each color represents the measures for an individual patient over time (n = 8). r and P values for rank-based relationship, accounting for repeated measures.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts